Search Results - "Eloseily, Esraa"

Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis by Eloseily, Esraa M., Weiser, Peter, Crayne, Courtney B., Haines, Hilary, Mannion, Melissa L., Stoll, Matthew L., Beukelman, Timothy, Atkinson, T. Prescott, Cron, Randy Q.

“…Objective To assess the benefit of the recombinant human interleukin‐1 receptor antagonist anakinra in treating pediatric patients with secondary…”
Get full text

Bacteria-Associated Cytokine Storm Syndrome by Eloseily, Esraa M, Cron, Randy Q

“…While viruses are considered the most common infectious triggers for cytokine storm syndromes (CSS), a growing list of bacterial pathogens, particularly…”
Get more information

Pediatric-onset limited ANCA-associated vasculitis arising during pre-existing chronic recurrent multifocal osteomyelitis by Eloseily, Esraa, Henrickson, Michael

“…Abstract Background Granulomatosis with polyangiitis (GPA) is an autoimmune disease characterized by chronic vasculitis involving small to medium sized…”
Get full text

Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis by Eloseily, Esraa M. A., Minoia, Francesca, Crayne, Courtney B., Beukelman, Timothy, Ravelli, Angelo, Cron, Randy Q.

“…Objective Macrophage activation syndrome (MAS) is a life‐threatening complication of systemic juvenile idiopathic arthritis (sJIA). Early diagnosis is…”
Get full text

Role of DOCK8 in cytokine storm syndromes by Zhang, Mingce, Cron, Remy R., Chu, Niansheng, Nguyen, Junior, Gordon, Scott M., Eloseily, Esraa M., Atkinson, T. Prescott, Weiser, Peter, Walter, Mark R., Kreiger, Portia A., Canna, Scott W., Behrens, Edward M., Cron, Randy Q.

“…Cytokine storm syndromes (CSSs), including hemophagocytic lymphohistiocytosis (HLH), are increasingly recognized as hyperinflammatory states leading to…”
Get full text

Upregulation of Cytotoxic T-cells in pediatric patients with Gaucher disease by Zahran, Asmaa M., Saad, Khaled, Elsayh, Khalid I., Abdou, Madleen Adel A., Abo-Elgheet, Amir M., Eloseily, Esraa M., Khalaf, Shaimaa M., Sror, Shabaan, Ahmad, Faisal-Alkhateeb, Elhoufey, Amira, Ghandour, Aliaa, Osman, Naglaa S.

“…Cytotoxic (CD8) T-cells and natural killer (NK) cells have a significant immune function role. The ongoing stimulation of immunity and the excessive release of…”
Get full text

Effects of royal jelly supplementation on regulatory T cells in children with SLE by Zahran, Asmaa M., Elsayh, Khalid I., Saad, Khaled, Eloseily, Esraa M.A., Osman, Naglaa S., Alblihed, Mohamd A., Badr, Gamal, Mahmoud, Mohamed H.

“…To our knowledge, no previous studies have focused on the immunomodulatory effects of fresh royal jelly (RJ) administration on systemic lupus erythematosus…”
Get full text

Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature by Crayne, Courtney B, Eloseily, Esraa, Mannion, Melissa L, Azerf, Saji P, Weiser, Peter, Beukelman, Timothy, Stoll, Matthew L, Feig, Daniel I, Prescott Atkinson, T, Cron, Randy Quentin

“…Henoch-Schonlein purpura (HSP) is a small vessel vasculitis that is characterized by non-thrombocytopenic purpura, abdominal pain, arthritis, and…”
Get full text

Down-regulation of Regulatory T-cells in Children With Gaucher Disease Under Enzyme Replacement Therapy by Zahran, Asmaa M., Saad, Khaled, Abo-Elela, Mohamed Gamil, Eloseily, Esraa M., Gad, Eman F., Elgheet, Amir M. Abo, Mahmmoud, Rasha R., Youssef, Mervat A. M., Abdelmeguid, Mona M., Hawary, Bahaa, Darwish, Sanaa F., Elhoufey, Amira, Elsayh, Khalid I.

“…Gaucher disease (GD) is one of the most important lysosomal storage disorders. T-lymphocytes perform and regulate many of the immune processes and play a major…”
Get full text

Predictive Biomarkers of Tofacitinib Responses and Disease Activity in Juvenile Idiopathic Arthritis Subtypes: A Longitudinal Study by Eloseily, Esraa

“…Objectives To investigate the value of candidate blood-based biomarkers (CBB) in predicting treatment response in juvenile idiopathic arthritis (JIA) treated…”
Get full text

Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction by Eloseily, Esraa, Pickering, Alex, Dhakal, Sanjeev, Ruperto, Nicolino, Brunner, Hermine I., Grom, Alexi A., Thornton, Sherry

“…Objectives To assess changes in gene expression following tofacitinib treatment and investigate transcription patterns as potential predictors of treatment…”
Get full text

Biomarker Changes in Response to Tofacitinib Treatment in Patients with Polyarticular Course Juvenile Idiopathic Arthritis by Ogbu, Ekemini A, Brunner, Hermine I, Eloseily, Esraa, Butbul Aviel, Yonatan, Nanda, Kabita, Schmeling, Heinrike, Tory, Heather, Uziel, Yosef, Viola, Diego Oscar, Wahezi, Dawn M, Tarvin, Stacey E, Sproles, Alyssa, Chen, Chen, Ruperto, Nicolino, Huang, Bin, Grom, Alexei, Thornton, Sherry

“…Examine levels of candidate blood-based biomarkers (CBB) in juvenile idiopathic arthritis (JIA) treated with tofacitinib. JIA patients who participated in…”
Get full text

Effects of royal jelly supplementation on regulatory T cells in children with SLE by Zahran, Asmaa M, Elsayh, Khalid I, Saad, Khaled, Eloseily, Esraa M A, Osman, Naglaa S, Alblihed, Mohamd A, Badr, Gamal, Mahmoud, Mohamed H

“…To our knowledge, no previous studies have focused on the immunomodulatory effects of fresh royal jelly (RJ) administration on systemic lupus erythematosus…”
Get full text

Effects of royal jelly supplementation on regulatory T cells in children with SLE by Zahran, Asmaa M, Elsayh, Khalid I, Saad, Khaled, Eloseily, Esraa M.A, Osman, Naglaa S, Alblihed, Mohamd A, Badr, Gamal, Mahmoud, Mohamed H

“…Inneholder sammendrag…”
Get full text